CN101433241A - Formula bovine colostrum - Google Patents
Formula bovine colostrum Download PDFInfo
- Publication number
- CN101433241A CN101433241A CNA2008102444694A CN200810244469A CN101433241A CN 101433241 A CN101433241 A CN 101433241A CN A2008102444694 A CNA2008102444694 A CN A2008102444694A CN 200810244469 A CN200810244469 A CN 200810244469A CN 101433241 A CN101433241 A CN 101433241A
- Authority
- CN
- China
- Prior art keywords
- bovine colostrum
- formula
- bovine
- colostrum
- lecithin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses formula bovine colostrum, which belongs to the technical field of food, medicine and health care products. The formula bovine colostrum consists of the following raw materials by weight portion ratio: 100 portions of bovine colostrum powder, 3.0 to 4.5 portions of procyanidine, 18 to 23 portions of lecithin, and 1 to 3 portions of folium ginkgo extract. The formula bovine colostrum has the advantages that the formula bovine colostrum is suitable to be taken by middle-aged and elderly persons, and has an ideal immunoregulation function, remarkable health care effect on delaying the aging, preventing cardiovascular diseases and preventing senile dementia, and obvious effect on memory improvement.
Description
Technical field
The invention belongs to food, medicine and health product technology field, be specifically related to a kind of formula bovine colostrum that is applicable to the elderly.
Background technology
Colostrum is a secreted milk in three days behind the cow birth, and its protein, fat, inorganic salts, vitamin equal size are significantly higher than normal breast, have very high nutritive value.The valuable point of colostrum not only is to contain a large amount of nutriments, priorly is to contain the multiple active immne factor that can strengthen immunologic function.Wherein most important is exactly active immune globulin (IgG), and it is a most important immunizing composition in the colostrum, can carry out specific the combination with antigens such as the bacterium of invading human body, viruses, thereby makes their forfeiture pathogenecities, improves immunity of organisms.
Colostrum is that the very wide immunity of a kind of scope of application strengthens product, no matter is children, teenager, or the elderly, and almost age level can be taken and uses enhancing autoimmunity entirely.Yet for the elderly, the health care of colostrum mainly is to improve immunity, and for example the health-care effect of angiocardiopathy, senile dementia and histoorgan aging etc. is remarkable inadequately to some common healthy elder problems.
At present, the preparation method of disclosed formula bovine colostrum such as disclosed immune bovine colostrum of Chinese invention patent application publication number CN 101219152A and bifidobacteria composite tiny capsule and pill, and the disclosed a kind of colostrum of CN 1762391A and lentinus edodes extracts composition and its production and use, the Beestings recombined health beverage that CN 1149967A announces, a kind of colostrum extract enriched composite powder that CN 1390465A announces, colostrum product with rich nutrients and manufacture method thereof that Chinese invention patent mandate publication number CN 1073356C announces.The product of above-mentioned announcement is not all developed at mid-aged population.
In view of this, be necessary to develop formula bovine colostrum at mid-aged population, strengthening immunity, the oxidation resistance of mid-aged population, and auxiliary antilipemic, improvement memory.
Summary of the invention
Task of the present invention is to provide a kind of the elderly of helping to take and uses the immunity that strengthens the elderly, the formula bovine colostrum that improves oxidation resistance, auxiliary antilipemic and improvement memory.
Task of the present invention is finished like this, a kind of formula bovine colostrum, and it is that raw material by following weight part ratio constitutes: 100 parts of bovine colostrums, 3.0-4.5 parts of OPCs, 18-23 parts in lecithin, 1-3 parts of ginkgo biloba p.es.
A kind of formula bovine colostrum, it is that raw material by following weight part ratio constitutes: 100 parts of bovine colostrums, 3.25-4.35 parts of OPCs, 18.4-22.6 parts in lecithin, ginkgo biloba p.e 1.15-2.63 part.
Bovine colostrum of the present invention is the bovine colostrum that meets standard RHB602-2005.
Bovine colostrum of the present invention is an immunoglobulin content greater than 35% bovine colostrum.
The OPC of OPC of the present invention for from grape pip, being extracted.
The lecithin of lecithin of the present invention for from soybean, being extracted.
Formula bovine colostrum provided by the present invention be suitable for the elderly take and have desirable immunoloregulation function and delay senility significantly, the health-care effect of angiocardiopathy preventing, prevention senile dementia, and the positive effect that improves memory.
The specific embodiment
OPC in the prescription provided by the present invention is a kind of bioflavonoid that special molecular structure is arranged, and is the most effective natural of free radical in the removing human body of generally acknowledging in the world at present, has effects such as anti-inflammatory, antitumor and protection cardiac muscle cell.Be generally the rufous powder, little, the puckery of gas, water-soluble and most organic solvent.Be generally grape seed extract or French maritime pine bark extract.OPC (grape seed extract) is a kind of high-efficiency antioxidant agent, has very strong activity in vivo.
Lecithin in the prescription provided by the present invention belongs to a kind of mixture, be the one group of filemot oil material that is present among animal vegetable tissue and the yolk, its constituent comprises phosphoric acid, choline, aliphatic acid, glycerine, glycolipid, triglyceride and phosphatide.Normally among yolk or soybean, isolate lecithin.Soybean lecithin is the byproduct in the refined soybean oil process.Granular on the market soybean lecithin is the Phospholipids that soybean oil is precipitated out in the process of coming unstuck, again the product after processing, drying.Contain lecithin, cephalin, cuorin, phosphatidic acid, phosphatidyl glycerol, plasmalogen, lysophosphatide etc. in the soybean lecithin.Main effect is to delay senility, prevents cardiovascular and cerebrovascular disease, prevention senile dementia.
Ginkgo biloba p.e provided by the present invention is to extract from ginkgo leaf and the mixture that goes out, and main component is GINKGO BILOBA EXTRACT, ginkgolides.Have the removing free radical, suppress cell membrane lipid peroxidation.Can also the antagonism platelet activation because of the platelet aggregation that causes, the formation of microthrombus.To brain blood circulation and brain cell metabolism, have and improve preferably and facilitation.Show that through clinical research ginkgo biloba p.e has significant curative effect to preventing and treating coronary heart disease, angina pectoris, miocardial infarction, cerebral embolism, cerebral angiospasm, post-traumatic brain syndrome, senile dementia and hypophrenia etc.
Embodiments of the invention 1-4 are by shown in the following table:
| Bovine colostrum (/g) | OPC (/g) | Lecithin (/g) | Ginkgo biloba p.e (/g) | |
| Embodiment 1 | 100 | 3.25 | 22.6 | 1.7 |
| Embodiment 2 | 100 | 4.35 | 20 | 2.5 |
| Embodiment 3 | 100 | 3.7 | 18.5 | 1.15 |
| Embodiment 4 | 100 | 4.0 | 19.2 | 2.6 |
Bovine colostrum described in the foregoing description is and meets standard RHB602-2005 and immunoglobulin content and be bovine colostrum greater than 35%; The extract that OPC described in the foregoing description is from grape pip and is extracted is a grape pip procyanidin; The extract that lecithin described in the foregoing description is from soybean and is extracted is a soybean lecithin; The described ginkgo biloba p.e of the foregoing description is preferred but not selects the trade mark of using by the production of Xuzhou City, Jiangsu Province, China East Sea biological products Co., Ltd with being limited to is YX-Y-50 type ginkgo leaf extractant.As long as above-mentioned four kinds of raw materials are fully mixed and by quantitative package.
To by the resulting mixture of the foregoing description, strengthen the experiment of immunologic function, anti-oxidation function and auxiliary lipid-lowering function and auxiliary improving memory function, concrete experimental technique is all with reference to " health food check and assessment technique standard ".The result is as shown in the table: (testing used control sample group is to take from same batch single bovine colostrum, and experimental result is represented with the merchant that embodiment tests average and sample sets experiment average, more clear and intuitive.)
As seen from the above table, formula bovine colostrum of the present invention is compared with single bovine colostrum and is had the following advantages: one, and stronger immunoloregulation function; Two, have delay senility more significantly, the health-care effect of angiocardiopathy preventing and prevention senile dementia.Therefore more be applicable to hypoimmunity, weak and sickly mid-aged population.
Claims (6)
1, a kind of formula bovine colostrum is characterized in that it is that raw material by following weight part ratio constitutes: 100 parts of bovine colostrums, 3.0-4.5 parts of OPCs, 18-23 parts in lecithin, 1-3 parts of ginkgo biloba p.es.
2, a kind of formula bovine colostrum is characterized in that it is that raw material by following weight part ratio constitutes: 100 parts of bovine colostrums, 3.25-4.35 parts of OPCs, 18.4-22.6 parts in lecithin, ginkgo biloba p.e 1.15-2.63 part.
3, formula bovine colostrum according to claim 1 and 2 is characterized in that described bovine colostrum is the bovine colostrum that meets standard RHB602-2005.
4, formula bovine colostrum according to claim 1 and 2 is characterized in that described bovine colostrum is an immunoglobulin content greater than 35% bovine colostrum.
5, formula bovine colostrum according to claim 1 and 2 is characterized in that the OPC of described OPC for being extracted from grape pip.
6, formula bovine colostrum according to claim 1 and 2 is characterized in that the lecithin of described lecithin for being extracted from soybean.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008102444694A CN101433241A (en) | 2008-12-05 | 2008-12-05 | Formula bovine colostrum |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008102444694A CN101433241A (en) | 2008-12-05 | 2008-12-05 | Formula bovine colostrum |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101433241A true CN101433241A (en) | 2009-05-20 |
Family
ID=40708002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008102444694A Pending CN101433241A (en) | 2008-12-05 | 2008-12-05 | Formula bovine colostrum |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101433241A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102511548A (en) * | 2011-12-29 | 2012-06-27 | 内蒙古伊利实业集团股份有限公司 | Milk flavored nutrient solution, and making method and application thereof |
| CN102047975B (en) * | 2009-11-06 | 2013-07-31 | 内蒙古伊利实业集团股份有限公司 | Grape seed extract-containing liquid dairy product and preparation method thereof |
| US20140004205A1 (en) * | 2011-03-18 | 2014-01-02 | Nestec Sa | Compositions and methods useful for ameliorating age related maladies |
| CN103704351A (en) * | 2014-01-22 | 2014-04-09 | 肖可韬 | Pawpaw bovine colostrum powder and preparation method thereof |
| CN108124963A (en) * | 2017-11-27 | 2018-06-08 | 海南国健高科技乳业有限公司 | A kind of Beestings recombined nutrient powder and preparation method thereof |
| CN115486480A (en) * | 2022-10-09 | 2022-12-20 | 江苏天美健大自然生物工程有限公司 | Bovine colostrum freeze-dried powder tablet and preparation method thereof |
-
2008
- 2008-12-05 CN CNA2008102444694A patent/CN101433241A/en active Pending
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102047975B (en) * | 2009-11-06 | 2013-07-31 | 内蒙古伊利实业集团股份有限公司 | Grape seed extract-containing liquid dairy product and preparation method thereof |
| US20140004205A1 (en) * | 2011-03-18 | 2014-01-02 | Nestec Sa | Compositions and methods useful for ameliorating age related maladies |
| CN104066342A (en) * | 2011-03-18 | 2014-09-24 | 雀巢产品技术援助有限公司 | Compositions and methods useful for ameliorating age related maladies |
| US10010566B2 (en) * | 2011-03-18 | 2018-07-03 | NestecSA | Compositions and methods useful for ameliorating age related maladies |
| CN102511548A (en) * | 2011-12-29 | 2012-06-27 | 内蒙古伊利实业集团股份有限公司 | Milk flavored nutrient solution, and making method and application thereof |
| CN102511548B (en) * | 2011-12-29 | 2013-04-10 | 内蒙古伊利实业集团股份有限公司 | Milk flavored nutrient solution, and making method and application thereof |
| CN103704351A (en) * | 2014-01-22 | 2014-04-09 | 肖可韬 | Pawpaw bovine colostrum powder and preparation method thereof |
| CN103704351B (en) * | 2014-01-22 | 2015-10-28 | 肖可韬 | Pawpaw bovine colostrum powder and preparation method |
| CN108124963A (en) * | 2017-11-27 | 2018-06-08 | 海南国健高科技乳业有限公司 | A kind of Beestings recombined nutrient powder and preparation method thereof |
| CN115486480A (en) * | 2022-10-09 | 2022-12-20 | 江苏天美健大自然生物工程有限公司 | Bovine colostrum freeze-dried powder tablet and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11166998B2 (en) | Eurycoma longifolia extract and its use in enhancing and/or stimulating immune system | |
| US11564952B2 (en) | Water-soluble and water-insoluble propolis products with high antioxidant capacity and their production methods | |
| KR101390044B1 (en) | Visceral fat accumulation inhibitor, and agent for promoting the increase in and/or inhibiting the decrease in blood adiponectin level | |
| CN101433241A (en) | Formula bovine colostrum | |
| CA3103132A1 (en) | Intact pea protein-based nutrient composition | |
| EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) et al. | Scientific Opinion on taxifolin‐rich extract from Dahurian Larch (Larix gmelinii) | |
| JP2023025192A (en) | Composition containing oleuropein or curcumin for muscle quality and/or mascle mass and its method | |
| Uchendu et al. | Hypolipidaemic and renoprotective effects of Glycine max (soy bean) against lipid profile and renal biochemical alterations in hypercholesterolemic rat | |
| KR20150055876A (en) | Composition for reducing body-fat and weight | |
| Reshetnik et al. | Healthy food products with probiotic and prebiotic properties | |
| KR100445685B1 (en) | Medium composition for lactobacillus comprising mushroom powder or mushroom extracts, composition of mushroom lactic acid fermentation using the medium composition, and method for manufacturing the composition of mushroom lactic acid fermentation | |
| US6841180B2 (en) | Method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby | |
| CN102379415A (en) | Antioxidant healthcare capsule and preparation method thereof | |
| WO2002011744A1 (en) | A strong antioxidant composite capsule containing grape seed extract opc and process for producing the same | |
| JP2003024010A (en) | Function-enhancing supplementary food comprising as main ingredient green tea catechin | |
| CN107372861B (en) | Composition and application thereof in preparation of product for improving hyperlipidemia | |
| RU2400107C1 (en) | Dietary supplement | |
| RU2419446C1 (en) | Composition of dense extract of conifer needles for capsulation | |
| Al-Musodi | Effect of Dietary Pomegranate Pomace Powder and/or Saccharomyces Cerevisiae in Some Productive and Physiological Traits in Local Male Lambs | |
| CN104958345A (en) | Soybean lecithin soft capsule with lipid-reducing function and preparation method thereof | |
| KR101735294B1 (en) | Composition for preventing or treating of oxidative brain injury and brain function disorder | |
| WO2010064882A1 (en) | Thick pine needle extract composition for capsulation | |
| KR101487245B1 (en) | Yakgwa comprising red ginseng and Preparation method thereof | |
| EP2599393A1 (en) | Oily preparations of and with lecithinen without ether phospholipids for protective, dietary, cosmetic compositions or remedy for sensitive persons | |
| KR20190079899A (en) | Jellied food with Immune Enhancing Effect Containing Soy Milk and Lactic Acid Bacteria and Its Preparation Method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090520 |